Aileron Therapeutics Statistics

Total Valuation

ALRN has a market cap or net worth of $76.05 million. The enterprise value is $93.94 million.

Market Cap	76.05M
Enterprise Value	93.94M

Important Dates

The next estimated earnings date is Tuesday, October 15, 2024, after market close.

Earnings Date	Oct 15, 2024
Ex-Dividend Date	n/a

Share Statistics

ALRN has 21.67 million shares outstanding. The number of shares has increased by 107.31% in one year.

Shares Outstanding	21.67M
Shares Change (YoY)	+107.31%
Shares Change (QoQ)	+139.85%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	30.95%
Float	19.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.26
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.69

Current Ratio	4.69
Quick Ratio	4.44
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.32% and return on invested capital (ROIC) is -28.03%.

Return on Equity (ROE)	-44.32%
Return on Assets (ROA)	-25.86%
Return on Capital (ROIC)	-28.03%
Revenue Per Employee	n/a
Profits Per Employee	-$1.68M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +149.61% in the last 52 weeks. The beta is 2.35, so ALRN's price volatility has been higher than the market average.

Beta (5Y)	2.35
52-Week Price Change	+149.61%
50-Day Moving Average	2.70
200-Day Moving Average	3.81
Relative Strength Index (RSI)	58.43
Average Volume (20 Days)	105,024

Short Selling Information

The latest short interest is 257,059, so 1.19% of the outstanding shares have been sold short.

Short Interest	257,059
Short Previous Month	296,750
Short % of Shares Out	1.19%
Short % of Float	1.32%
Short Ratio (days to cover)	5.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.52M
Pretax Income	-18.07M
Net Income	-25.22M
EBITDA	-25.40M
EBIT	-25.52M
Earnings Per Share (EPS)	-$2.68

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	21.92M
Total Debt	n/a
Net Cash	21.92M
Net Cash Per Share	$1.01
Equity (Book Value)	101.02M
Book Value Per Share	2.59
Working Capital	18.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-25.69M
Capital Expenditures	n/a
Free Cash Flow	-25.69M
FCF Per Share	-$1.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-107.31%
Shareholder Yield	-107.31%
Earnings Yield	-35.60%
FCF Yield	-36.26%

Analyst Forecast

The average price target for ALRN is $19.00, which is 441.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.00
Price Target Difference	441.31%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.20%

Stock Forecasts

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a